In hippocampus endocannabinoids modulate synaptic function and plasticity a
nd increase tyrosine phosphorylation of several proteins, including focal a
dhesion kinase (FAK). Autophosphorylation of FAK on Tyr-397 is generally a
critical step for its activation, allowing the recruitment of Src family ki
nases, and phosphorylation of FAK and associated proteins. We have examined
the mechanisms of the regulation of FAK by cannabinoids in rat and mouse h
ippocampal slices. Anandamide and 2-arachidonoylglycerol, two endocannabino
ids, and Delta9-tetrahydrocannabinol, stimulated tyrosine phosphorylation o
f FAK(+)6,7, a neuronal splice isoform of FAK, on several residues includin
g Tyr-397. Cannabinoids increased phosphorylation of p130-Cas, a protein as
sociated with FAK, but had no effect on PYK2, a tyrosine kinase related to
FAK and enriched in hippocampus. Pharmacological experiments and the use of
knockout mice demonstrated that the effects of cannabinoids were mediated
through CB1 receptors. These effects were sensitive to manipulation of cAMP
-dependent protein kinase, suggesting that they were mediated by inhibition
of a cAMP pathway. PP2, an Sre family kinase inhibitor, prevented the effe
cts of cannabinoids on p130-Cas and on FAK(+)6,7 tyrosines 577 and 925, but
not 397, indicating that FAK autophosphorylation was upstream of Src famil
y kinases in response to CB1-R stimulation. Endocannabinoids increased the
association of Fyn, but not Sre, with FAK(+)6,7. In hippocampal slices from
Fyn -/- mice, the levels of p130-Cas were increased, and the effects of en
docannabinoids on tyrosine phosphorylation, including of Tyr-397, were comp
letely abolished. These results demonstrate the specific functional associa
tion of Fyn with FAK(+)6,7 in a pathway regulated by endocannabinoids, in w
hich Fyn may play roles dependent and independent of its catalytic activity
.